SIGNUPABOUTBW_CONTENTSBW_+!DAILY_BRIEFINGSEARCHCONTACT_US


The New AstraZeneca

SALES: $11.5 billion

RESEARCH & DEVELOPMENT: $1.95 billion

OPERATING PROFITS: $3 billion

KEY DRUGS: Losec anti-ulcer, Zestril heart drug

BASED ON 1997 ACCOUNTS

DATA: ASTRA, ZENECA, BUSINESS WEEK


Return to main story


Updated Dec. 10, 1998 by bwwebmaster
Copyright 1998, Bloomberg L.P.
Terms of Use